GlassScriptPhysician profile
Mohammad A Sarraf
NPI 1689648735
$1,846.64
in general payments reported to CMS, 2019-2025
14 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $136 · 2021: $13.62 · 2022: $28.59 · 2023: $178 · 2024: $234 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.57 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $898.33 | 2019-2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $399.47 | 2019-2025 | Wainua, Airsupra, Tezspire |
| Mylan Specialty L.P. | $152.12 | 2019-2020 | |
| Glaxosmithkline, LLC. | $120.64 | 2019-2025 | Nucala, Trelegy Ellipta |
| Philips North America LLC | $87.25 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Novo Nordisk INC | $52.17 | 2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $34.00 | 2024 | |
| Mallinckrodt Hospital Products INC. | $18.76 | 2025 | Acthar |
| Janssen Pharmaceuticals, INC | $14.91 | 2020 | |
| Scpharmaceuticals INC. | $14.80 | 2025 | |
| Baxter Healthcare | $14.56 | 2025 | Hillrom - Monarch Airway Clearance System |
| Novartis Pharmaceuticals Corporation | $14.54 | 2024 | |
| Merck Sharp & Dohme LLC | $13.13 | 2019 | |
| Mallinckrodt Enterprises LLC | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Sarraf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.